Leap Therapeutics, Inc. (LPTX)
NASDAQ: LPTX · Real-Time Price · USD
0.480
-0.003 (-0.52%)
At close: Feb 21, 2025, 4:00 PM
0.476
-0.004 (-0.85%)
After-hours: Feb 21, 2025, 5:23 PM EST
Leap Therapeutics Employees
Leap Therapeutics had 54 employees as of December 31, 2023. The number of employees increased by 10 or 22.73% compared to the previous year.
Employees
54
Change (1Y)
10
Growth (1Y)
22.73%
Revenue / Employee
n/a
Profits / Employee
-$1,200,426
Market Cap
18.40M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
LPTX News
- 25 days ago - Leap Therapeutics Reports Initial Clinical Data from Part B of the DeFianCe Study and Part C of the DisTinGuish Study - PRNewsWire
- 6 weeks ago - Leap Therapeutics: A Buy On Near-Term Data Catalysts In Stomach And Colon Cancer - Seeking Alpha
- 6 weeks ago - Leap Therapeutics to Participate at the 43rd Annual J.P. Morgan Healthcare Conference - PRNewsWire
- 3 months ago - Leap Therapeutics to Participate at Piper Sandler 36th Annual Healthcare Conference - PRNewsWire
- 3 months ago - Leap Therapeutics Reports Third Quarter 2024 Financial Results - PRNewsWire
- 5 months ago - Leap Therapeutics Announces Completion of Enrollment in Part B of the DeFianCe Study of DKN-01 for the Treatment of Colorectal Cancer Patients - PRNewsWire
- 6 months ago - Leap Therapeutics Reports Second Quarter 2024 Financial Results - PRNewsWire
- 10 months ago - Leap Therapeutics Reports First Quarter 2024 Financial Results - PRNewsWire